Cargando…

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

The outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing worldwide attention. Cases of liver damage or dysfunction (mainly characterized by moderately elevated serum aspartate aminotransferase levels) ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Gong, Zheng, Kenneth I., Yan, Qin-Qin, Rios, Rafael S., Targher, Giovanni, Byrne, Christopher D., Poucke, Sven Van, Liu, Wen-Yue, Zheng, Ming-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132016/ https://www.ncbi.nlm.nih.gov/pubmed/32274342 http://dx.doi.org/10.14218/JCTH.2020.00018

Ejemplares similares

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease
por: Liu, Wen-Yue, et al.
Publicado: (2021)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
por: Miao, Lei, et al.
Publicado: (2022)

Current and emerging therapeutic strategies for Fanconi anemia
por: Shukla, Pallavi, et al.
Publicado: (2012)

PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease
por: Li, Gang, et al.
Publicado: (2022)

Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies
por: Khullar, Naina, et al.
Publicado: (2023)

Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
por: Zhang, Xin-Lei, et al.
Publicado: (2022)

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction
por: Chung, Eric
Publicado: (2019)

Myelofibrosis-Related Anemia: Current and Emerging Therapeutic Strategies
por: Naymagon, Leonard, et al.
Publicado: (2017)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
por: Zhou, Xiao-Dong, et al.
Publicado: (2022)

Astrocytes as a target for therapeutic strategies in epilepsy: current insights
por: Çarçak, Nihan, et al.
Publicado: (2023)

Neuroinflammation as the Underlying Mechanism of Postoperative Cognitive Dysfunction and Therapeutic Strategies
por: Li, Zhichao, et al.
Publicado: (2022)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
por: Evers, Melvin M., et al.
Publicado: (2013)

Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis
por: Xu, Ke, et al.
Publicado: (2022)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis
por: Stoess, Christian, et al.
Publicado: (2023)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
por: Targher, Giovanni
Publicado: (2020)

Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
por: Kadel, Dhruba, et al.
Publicado: (2019)

Current Analytical Strategies for Antibody–Drug Conjugates in Biomatrices
por: Qin, Qiuping, et al.
Publicado: (2022)

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
por: Targher, G., et al.
Publicado: (2020)

Current therapeutic strategies for respiratory diseases using mesenchymal stem cells
por: Wang, Ming‐yao, et al.
Publicado: (2021)

Nrf2 Pathway and Autophagy Crosstalk: New Insights into Therapeutic Strategies for Ischemic Cerebral Vascular Diseases
por: Hu, Yue, et al.
Publicado: (2022)

Emerging diagnostic and therapeutic strategies for urothelial carcinoma
por: Moschini, Marco, et al.
Publicado: (2021)

Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction
por: Darwish, Ilyse, et al.
Publicado: (2013)

Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies
por: Abedalthagafi, Malak
Publicado: (2018)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

Oxidative Stress and Vascular Dysfunction in the Retina: Therapeutic Strategies
por: Ruan, Yue, et al.
Publicado: (2020)

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights
por: Khatua, Soumen, et al.
Publicado: (2018)

Citrus Genetic Transformation: An Overview of the Current Strategies and Insights on the New Emerging Technologies
por: Conti, Gabriela, et al.
Publicado: (2021)

Current diagnostics and treatment of fibrosarcoma –perspectives for future therapeutic targets and strategies
por: Augsburger, Daniela, et al.
Publicado: (2017)

Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels
por: Zheng, Kenneth I, et al.
Publicado: (2020)

Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease
por: Ghosh, Shampa, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
por: Bonapace, Stefano, et al.
Publicado: (2012)

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies
por: Kaur, Raminderjit, et al.
Publicado: (2018)

New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia
por: Smolewski, Piotr, et al.
Publicado: (2013)

Chronic Pain after Bone Fracture: Current Insights into Molecular Mechanisms and Therapeutic Strategies
por: Zhao, Yuying, et al.
Publicado: (2022)

Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives
por: Almansa-Gómez, Sergio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_srls759v90v5v1vrjmalu7974c